Key takeaways
- Every draw contains every peptide. A blend cannot deliver one component without the others.
- Each peptide has its own concentration: its own mg × 1000 ÷ water in mL.
- “Dose by one component” and “Dose by total blend” give different draws. In a 1:1 blend, a total amount holds only half of each peptide.
- Confirm whether the label mg is per peptide or total. Guessing wrong halves or doubles every result.
- None of these peptides is an FDA-approved drug, and BPC-157, TB-500, CJC-1295 and ipamorelin are all on WADA’s 2026 Prohibited List.
How to use the peptide blend calculator
A blend is a single vial that holds two or more peptides freeze-dried together. After you add water, the peptides share the same liquid, so you cannot draw one without the others. The calculator handles that for you in five steps.
- List every peptide and its mg. Use the per-peptide amounts from the label. Tap a preset to fill common compositions, then check each number against your vial. Add up to four rows.
- Enter the water. Type the mL of bacteriostatic water you add. Tap a preset volume to compare options before you mix.
- Say how your amount is written. Choose Dose by one component when your notes give an amount for one peptide, such as 250 mcg of BPC-157. Choose Dose by total blend when the amount covers everything in the vial combined.
- Enter the amount and pick the syringe. The amount is an arithmetic input only. Choose 0.3, 0.5 or 1 mL. Tick U-40 only if the syringe says U-40.
- Read the draw and the table. The big number is the unit mark. The table shows each peptide’s concentration and how much of it that draw holds. Show the math lists every step.
Is “10 mg” per peptide or total?
This is the most common blend error, and no calculator can fix it for you. A vial labeled “BPC-157/TB-500 10 mg” can mean two very different things: 5 mg of each peptide (10 mg total), or 10 mg of each (20 mg total). Labels are not standardized, so look for a per-peptide breakdown on the vial, the box or the certificate of analysis (COA), the lab report that lists what a batch contains.
The table below shows why it matters. It uses 2 mL of water and an example amount of 250 mcg of BPC-157 for each reading of the same label.
| Label read as | Total in vial | Each peptide | Each per 10 units | Units for the example |
|---|---|---|---|---|
| 10 mg total (5 + 5) | 10 mg | 2.5 mg/mL | 250 mcg | 10 units |
| 10 mg of each (10 + 10) | 20 mg | 5 mg/mL | 500 mcg | 5 units |
If the vial really holds 5 mg of each but you calculate as if it holds 10 mg of each, you draw 5 units and get 125 mcg of BPC-157 instead of 250 mcg: half. If the vial really holds 10 mg of each and you assume 5 mg, you draw 10 units and get 500 mcg: double. The calculator shows a Per peptide or total? note whenever the rows are equal, because that is when the mix-up is most likely.
How one draw from a blend splits into its peptides
The diagram follows a GLOW vial mixed with 2 mL of water. The total concentration is 35 mg/mL, but that single number hides three different concentrations, one per peptide.
Peptide blend formulas
A blend is several ordinary reconstitution problems that share one volume of water. Work each peptide out separately, then link them through the volume you draw.
Use only that peptide’s mg, not the vial total.
Shortcut for U-100: units = Di (mcg) × water (mL) ÷ (mgi × 10). Check: 250 × 2 ÷ (5 × 10) = 10 units.
| Symbol | Meaning | Unit |
|---|---|---|
| mgi | Amount of one peptide in the vial | mg |
| Water | Diluent added to the vial | mL |
| Ci | Concentration of one peptide after mixing | mcg/mL |
| Ctotal | All peptides combined per mL | mcg/mL |
| Di, Dtotal | Amount of one peptide, or of the whole blend, in one draw | mcg |
| V | Volume drawn | mL (× 100 = U-100 units) |
Worked examples
Every amount below is an example input chosen to show the arithmetic. None is a suggested dose.
Example 1: BPC-157 5 mg + TB-500 5 mg, 2 mL, 250 mcg of BPC-157
BPC-157 concentration is 5 × 1000 ÷ 2 = 2,500 mcg/mL. The volume is 250 ÷ 2,500 = 0.1 mL, or 10 units. TB-500 has the same concentration, so the draw also holds 250 mcg of TB-500, 500 mcg of blend in all. The vial holds 20 such draws.
Example 2: the same vial, 250 mcg written as total blend
The total concentration is 5,000 mcg/mL, so 250 mcg of blend is 0.05 mL, or 5 units. That draw holds only 125 mcg of each peptide. Reading a total amount as a per-peptide one, or the reverse, is a two-fold error in a 1:1 blend.
Example 3: GLOW in 3 mL, 500 mcg of BPC-157
BPC-157 is 10 mg of the vial, so its concentration is 3,333.3 mcg/mL. 500 mcg is 0.15 mL, or 15 units, which fits a 0.5 mL syringe. The same draw carries 2.5 mg of GHK-Cu and 500 mcg of TB-500, 3.5 mg in total. The vial holds 20 draws.
Example 4: CJC-1295 (no DAC) 5 mg + ipamorelin 5 mg, 2.5 mL, 100 mcg of CJC-1295
Each peptide is 2,000 mcg/mL. 100 mcg is 0.05 mL, or 5 units, with 100 mcg of ipamorelin alongside. A draw this small is easier to read on a 0.3 mL syringe, which is often marked in half units. The vial holds 50 draws.
Example 5: KLOW in 2 mL, 4 mg written as total blend
80 mg in 2 mL is 40 mg/mL in total, so 4 mg of blend is 0.1 mL, or 10 units. It splits into 2.5 mg GHK-Cu, 500 mcg BPC-157, 500 mcg TB-500, 500 mcg KPV.
Blend charts: what 10 units contains
These charts show how much of each peptide sits in 10 units (0.1 mL) of a U-100 syringe for the preset compositions. Divide an amount by the “per 10 units” value and multiply by 10 to get units. For any other volume or composition, use the calculator above.
| Blend | Water | Total conc. | Each peptide | Blend total |
|---|---|---|---|---|
| BPC-157 + TB-500, 5/5 mg | 1 mL | 10 mg/mL | 500 mcg | 1 mg |
| BPC-157 + TB-500, 5/5 mg | 2 mL | 5 mg/mL | 250 mcg | 500 mcg |
| BPC-157 + TB-500, 5/5 mg | 3 mL | 3.33 mg/mL | 166.67 mcg | 333.33 mcg |
| BPC-157 + TB-500, 10/10 mg | 1 mL | 20 mg/mL | 1 mg | 2 mg |
| BPC-157 + TB-500, 10/10 mg | 2 mL | 10 mg/mL | 500 mcg | 1 mg |
| BPC-157 + TB-500, 10/10 mg | 3 mL | 6.67 mg/mL | 333.33 mcg | 666.67 mcg |
| CJC-1295 (no DAC) + Ipamorelin, 5/5 mg | 1 mL | 10 mg/mL | 500 mcg | 1 mg |
| CJC-1295 (no DAC) + Ipamorelin, 5/5 mg | 2 mL | 5 mg/mL | 250 mcg | 500 mcg |
| CJC-1295 (no DAC) + Ipamorelin, 5/5 mg | 3 mL | 3.33 mg/mL | 166.67 mcg | 333.33 mcg |
In a 1:1 blend, each peptide is exactly half of the blend total in any draw.
| Blend | Water | GHK-Cu | BPC-157 | TB-500 | KPV | Total |
|---|---|---|---|---|---|---|
| GLOW (50/10/10 mg) | 2 mL | 2.5 mg | 500 mcg | 500 mcg | — | 3.5 mg |
| GLOW (50/10/10 mg) | 2.5 mL | 2 mg | 400 mcg | 400 mcg | — | 2.8 mg |
| GLOW (50/10/10 mg) | 3 mL | 1.667 mg | 333.33 mcg | 333.33 mcg | — | 2.333 mg |
| KLOW (50/10/10/10 mg) | 2 mL | 2.5 mg | 500 mcg | 500 mcg | 500 mcg | 4 mg |
| KLOW (50/10/10/10 mg) | 2.5 mL | 2 mg | 400 mcg | 400 mcg | 400 mcg | 3.2 mg |
| KLOW (50/10/10/10 mg) | 3 mL | 1.667 mg | 333.33 mcg | 333.33 mcg | 333.33 mcg | 2.667 mg |
The same amount of one peptide can mean very different draws, and very different company, depending on the blend. Here is an example amount of 250 mcg of BPC-157 at 2 mL of water in each BPC-157 preset:
| Blend | Units | Also in the draw | Blend total |
|---|---|---|---|
| BPC-157 + TB-500, 5/5 mg | 10 | 250 mcg TB-500 | 500 mcg |
| BPC-157 + TB-500, 10/10 mg | 5 | 250 mcg TB-500 | 500 mcg |
| GLOW | 5 | 1.25 mg GHK-Cu, 250 mcg TB-500 | 1.75 mg |
| KLOW | 5 | 1.25 mg GHK-Cu, 250 mcg TB-500, 250 mcg KPV | 2 mg |
GLOW and KLOW blends: what the labels usually say
GLOW and KLOW are informal names used by research-peptide sellers, not drug names. The compositions below are the ones most often printed on labels. Products differ, so treat the presets as a starting point and always enter your own vial’s numbers.
- GLOW: GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg, 70 mg in total. GHK-Cu is a copper-binding tripeptide (glycyl-histidyl-lysine).
- KLOW: the GLOW trio plus KPV 10 mg, 80 mg in total. KPV is a three-amino-acid peptide (lysine-proline-valine) from the tail end of alpha-MSH, a natural hormone.
The practical point is the ratio. GHK-Cu is 71.4% of GLOW and 62.5% of KLOW by mass. So 1 mg of GLOW blend holds 714.29 mcg of GHK-Cu, 142.86 mcg of BPC-157, 142.86 mcg of TB-500. If your notes give an amount of BPC-157 and you enter it as a total-blend amount, the draw holds only one-seventh of that BPC-157. Use Dose by one component for that case. The BPC-157 calculator gives the same answer as a blend only if you enter the blend’s BPC-157 mg (10 mg in GLOW), not the vial total.
CJC-1295 and ipamorelin blend reconstitution
The usual label is CJC-1295 (no DAC) 5 mg + ipamorelin 5 mg in one 10 mg vial. “No DAC” means the version without the drug affinity complex, a chemical add-on that binds the peptide to albumin in the blood and makes it last much longer. The two versions are different substances, so check which one the label names.
Because the ratio is 1:1, the math is simple. With 2 mL of water, each peptide is 2.5 mg/mL and every U-100 unit holds 25 mcg of CJC-1295 and 25 mcg of ipamorelin. Divide an amount of either peptide by 25 to get units. If your notes give a combined amount, halve it first, or select Dose by total blend. To choose a water volume that lands your amount on a whole mark, use the BAC water calculator with the per-peptide mg (5 mg), not the vial total.
Regulatory and anti-doping status
None of the peptides in these presets is an FDA-approved drug. Their compounding status has changed several times since 2023, so here is the timeline from FDA’s own documents.
- September 29, 2023: FDA placed BPC-157, TB-500 (listed as thymosin beta-4 fragment LKKTETQ), CJC-1295, ipamorelin acetate, KPV and injectable GHK-Cu in Category 2 of its 503A bulk substances list: substances that raise significant safety concerns. For BPC-157, FDA cited a possible risk of immunogenicity (an immune reaction to the peptide) for certain routes of administration, and problems with peptide-related impurities and characterizing the active ingredient.
- April 2026: the nominators withdrew those nominations, and FDA moved the peptides to a list of substances “nominated but withdrawn.” FDA’s page still describes the same safety risks for each. Ipamorelin acetate remains in Category 2 for 503B outsourcing facilities.
- July 23, 2026: FDA’s Pharmacy Compounding Advisory Committee (PCAC) reviewed BPC-157, KPV, TB-500 and MOTs-C for the 503A bulks list. It voted 8–6, with one abstention, to recommend adding BPC-157, against the advice of FDA staff. The vote is non-binding. FDA makes the final decision, and a compounding listing would not be a drug approval.
For athletes, the rules are clearer. The WADA 2026 Prohibited List, in force from January 1, 2026, names BPC-157 under S0 (non-approved substances), CJC-1295 and ipamorelin under S2.2.4 (growth hormone releasing factors), and thymosin beta-4 derivatives such as TB-500 under S2.3 (growth factors). All are prohibited at all times, in and out of competition. GHK-Cu and KPV are not named, but S0 covers any substance with no current government approval for human therapeutic use, so check with your anti-doping organization.
| Peptide | FDA 503A compounding status | WADA 2026 list |
|---|---|---|
| BPC-157 | Category 2 from Sept 2023; nomination withdrawn Apr 2026; PCAC voted 8–6 in favor of the bulks list, July 2026 | S0 Non-approved substances (named) |
| TB-500 (thymosin beta-4 fragment) | Category 2 from Sept 2023; nomination withdrawn Apr 2026; reviewed by PCAC July 2026 | S2.3 Growth factors (named) |
| CJC-1295 | Category 2 from Sept 2023; nomination withdrawn Apr 2026 | S2.2.4 GHRH analogues (named) |
| Ipamorelin | Category 2 from Sept 2023; 503A nomination withdrawn Apr 2026; still Category 2 for 503B outsourcing facilities | S2.2.4 GH secretagogues (named) |
| GHK-Cu (injectable) | Category 2 from Sept 2023; nomination withdrawn Apr 2026 | Not named; see S0 |
| KPV | Category 2 from Sept 2023; nomination withdrawn Apr 2026; reviewed by PCAC July 2026 | Not named; see S0 |
Common blend mistakes
Each mistake below maps to a check in the calculator, so a warning appears before the number is used.
- Treating a total label as per peptide. A “10 mg” blend that is 5 + 5 entered as 10 + 10 halves the real amount in every draw. The Per peptide or total? note flags equal rows.
- Treating a total-blend amount as one peptide. 500 mcg of a 1:1 blend is 250 mcg of each. The Total, not per peptide note spells out the split.
- Typing the vial amount into the dose box. If one draw would use half the vial or more, the calculator asks whether you entered the label amount by mistake.
- Using a single-peptide calculator on a blend. Entering the vial total into the reconstitution calculator gives the blend’s total concentration, not any one peptide’s.
- Mixing up mg and mcg. 1 mg is 1,000 mcg. The mcg to mg converter helps when labels and notes use different units.
- Using a U-40 syringe. Each U-40 unit is 2.5 times the volume of a U-100 unit. The mg to units calculator explains the difference.
- Forgetting the vial runs out for every peptide at once. The doses per vial calculator shows how long a vial lasts at your schedule.
Key terms
- Blend
- One vial containing two or more peptides freeze-dried together and reconstituted in the same water.
- Component
- One peptide in a blend, such as BPC-157 in GLOW.
- Ratio
- The fixed proportion between components, such as 5 : 1 : 1 in GLOW. Adding water never changes it.
- Total concentration
- All components combined per mL. Useful only when your amount is written for the whole blend.
- Certificate of analysis (COA)
- A lab report listing what a batch contains, often including the per-peptide amounts.
- 503A bulks list
- FDA’s list of bulk drug substances that state-licensed pharmacies may use to compound for individual prescriptions.
- WADA S0
- The Prohibited List class for substances with no government approval for human therapeutic use.
Frequently asked questions
How do you calculate a peptide blend dose?
Work out each peptide’s concentration on its own: its mg × 1000 ÷ the water in mL. Divide the amount you want of that peptide by its concentration to get mL, then multiply by 100 for U-100 units. The other peptides come along in the label ratio. The reconstitution calculator covers single-peptide vials.
Is 10 mg on a blend vial per peptide or total?
It depends on the product, and labels are not consistent. “BPC-157/TB-500 10 mg” can mean 5 mg of each or 10 mg of each. Check the full label, the box or the certificate of analysis for a per-peptide breakdown. If you cannot confirm it, you cannot calculate a reliable draw.
How many units is 250 mcg of BPC-157 in a 5 mg/5 mg BPC-157 + TB-500 blend?
It depends on the water. BPC-157 alone is 5 mg of the vial, so with 1 mL it is 5 units, with 2 mL 10 units and with 3 mL 15 units. Each of those draws also contains 250 mcg of TB-500. This is arithmetic for an example amount, not a dose recommendation.
What is in a GLOW peptide blend?
The most common GLOW label is GHK-Cu 50 mg, BPC-157 10 mg and TB-500 10 mg, or 70 mg in total. GHK-Cu makes up 71.4% of that mass, so most of any draw is GHK-Cu. Compositions vary between products, so always use the numbers on your own vial.
What is in a KLOW peptide blend?
KLOW is usually GLOW plus KPV: GHK-Cu 50 mg, BPC-157 10 mg, TB-500 10 mg and KPV 10 mg, or 80 mg in total. GHK-Cu is 62.5% of the mass. Enter all four components, or tap the KLOW preset and check each value against your label.
How much water do you add to a CJC-1295 and ipamorelin 10 mg blend?
Any volume the vial holds works if you recalculate. With 2 mL, each peptide is 2.5 mg/mL, so every U-100 unit carries 25 mcg of CJC-1295 and 25 mcg of ipamorelin. The BAC water calculator can pick a volume that puts your amount on a whole-unit mark.
Can I change the amount of just one peptide in a blend?
No. Every draw holds all the peptides in the fixed label ratio, so changing the draw changes all of them together. Adding more water changes the concentration of every component equally but not the ratio. Independent amounts require separate single-peptide vials.
How much bacteriostatic water should I add to a GLOW or KLOW vial?
No volume is universally correct. More water lowers every concentration and makes each draw larger in volume. The blend charts on this page show what 10 units contains at 2, 2.5 and 3 mL. Make sure the volume fits your vial with room to spare.
Are BPC-157 and TB-500 banned in sport?
Yes. On WADA’s 2026 Prohibited List, BPC-157 is named under S0 non-approved substances and thymosin beta-4 derivatives such as TB-500 under S2.3 growth factors. CJC-1295 and ipamorelin are named under S2.2.4. All are prohibited at all times, in and out of competition.
Is this calculator a dosing recommendation?
No. It converts the numbers you enter into volume, units and per-peptide amounts. It does not suggest an amount, and the peptides in these presets are not FDA-approved drugs. For single-peptide math, use the BPC-157 calculator or the reverse peptide calculator.
Sources
We check every formula and figure on this page against primary sources. See our editorial policy for how we review content.
- Certain bulk drug substances for use in compounding that may present significant safety risks
- Bulk drug substances nominated for use in compounding under section 503A (update of September 29, 2023)
- July 23–24, 2026: Meeting of the Pharmacy Compounding Advisory Committee
- FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list
- In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
- World Anti-Doping Code International Standard: Prohibited List 2026
Reviewed by the PeptideConvert Editorial Team
Last reviewed . PeptideConvert tools do arithmetic only. They do not recommend a dose, and nothing on this site is medical advice. Always follow the label and your prescriber. Read the full medical disclaimer.